CareDx (CDNA)
(Delayed Data from NSDQ)
$7.98 USD
-0.25 (-3.04%)
Updated Apr 24, 2024 04:00 PM ET
3-Hold of 5 3
D Value C Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CDNA 7.98 -0.25(-3.04%)
Will CDNA be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CDNA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CDNA
CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last?
How CareDx (CDNA) Stock Stands Out in a Strong Industry
CDNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
CareDx (CDNA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Unlocking Q4 Potential of CareDx (CDNA): Exploring Wall Street Estimates for Key Metrics
How Much Upside is Left in CareDx (CDNA)? Wall Street Analysts Think 26.72%
Other News for CDNA
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
CareDx Appoints John W. Hanna as New CEO and Board Member
CareDx appoints John Hanna as president and CEO
CareDx names John Hanna as new CEO